Analysis of nuclear targeting activities of transport signals in the human immunodeficiency virus Rev protein

Experimental Cell Research

Volumn 291, Issue 2, 2003, Pages 484-501

  Demart, Séverine ^a   Ceccherini Silberstein, Francesca ^a,b   Schlicht, Stefan ^a   Walcher, Sebastian ^a   Wolff, Horst ^a   Neumann, Markus ^a   Erfle, Volker ^a   Brack Werner, Ruth ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Nuclear export signal; Nuclear localization; Nuclear localization signal; Rev; Shuttling

Indexed keywords

REV PROTEIN;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FLUORESCENCE MICROSCOPY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

HUMAN IMMUNODEFICIENCY VIRUS; NES;

EID: 0345304386     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2003.07.011     Document Type: Article

References (74)

1. Mattaj I.W., Englmeier L. Nucleocytoplasmic transport the soluble phase . Annu. Rev. Biochem. 67:1998;265-306.
2. Gorlich D., Kutay U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell. Dev. Biol. 15:1999;607-660.
3. Macara I.G. Transport into and out of the nucleus. Microbiol. Mol. Biol. Rev. 65:2001;570-594. , table of contents.
4. Yoneda Y., Hieda M., Nagoshi E., Miyamoto Y. Nucleocytoplasmic protein transport and recycling of Ran. Cell. Struct. Funct. 24:1999;425-433.
5. Imamoto N. Diversity in nucleocytoplasmic transport pathways. Cell. Struct. Funct. 25:2000;207-216.
6. Jans D.A., Xiao C.Y., Lam M.H. Nuclear targeting signal recognition a key control point in nuclear transport? Bioessays. 22:2000;532-544.
7. Michael W.M. Nucleocytoplasmic shuttling signals two for the price of one . Trends Cell. Biol. 10:2000;46-50.
8. Gama-Carvalho M., Carmo-Fonseca M. The rules and roles of nucleocytoplasmic shuttling proteins. FEBS Lett. 498:2001;157-163.
9. Rehberg S., Lischka P., Glaser G., Stamminger T., Wegner M., Rosorius O. Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation. Mol. Cell. Biol. 22:2002;5826-5834.
10. Bear J., Tan W., Zolotukhin A.S., Tabernero C., Hudson E.A., Felber B.K. Identification of novel import and export signals of human TAP, the protein that binds to the constitutive transport element of the type D retrovirus mRNAs. Mol. Cell. Biol. 19:1999;6306-6317.
11. Michael W.M., Eder P.S., Dreyfuss G. The K nuclear shuttling domain a novel signal for nuclear import and nuclear export in the hnRNP K protein . EMBO J. 16:1997;3587-3598.
12. Weighardt F., Biamonti G., Riva S. Nucleo-cytoplasmic distribution of human hnRNP proteins a search for the targeting domains in hnRNP A1 . J. Cell Sci. 108:1995;545-555.
13. Fan X.C., Steitz J.A. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17:1998;3448-3460.
14. Peng S.S., Chen C.Y., Xu N., Shyu A.B. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17:1998;3461-3470.
15. Tang H., McDonald D., Middlesworth T., Hope T.J., Wong-Staal F. The carboxyl terminus of RNA helicase A contains a bidirectional nuclear transport domain. Mol. Cell. Biol. 19:1999;3540-3550.
16. Greene W.C., Peterlin B.M. Charting HIV's remarkable voyage through the cell basic science as a passport to future therapy . Nat. Med. 8:2002;673-680.
17. Kjems J., Askjaer P. Rev protein and its cellular partners. Adv. Pharmacol. 48:2000;251-298.
18. Kubota S., Hatanaka M., Pomerantz R.J. Nucleo-cytoplasmic redistribution of the HTLV-I Rex protein alterations by coexpression of the HTLV-I p21x protein . Virology. 220:1996;502-507.
19. Sandri-Goldin R.M. Nuclear export of herpes virus RNA. Curr. Top. Microbiol. Immunol. 259:2001;2-23.
20. Boyer J.L., Swaminathan S., Silverstein S.J. The Epstein-Barr virus SM protein is functionally similar to ICP27 from herpes simplex virus in viral infections. J. Virol. 76:2002;9420-9433.
21. Whittaker G., Bui M., Helenius A. Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons. J. Virol. 70:1996;2743-2756.
22. Portela A., Digard P. The influenza virus nucleoprotein a multifunctional RNA-binding protein pivotal to virus replication . J. Gen. Virol. 83:2002;723-734.
23. Neumann M., Felber B.K., Kleinschmidt A., Froese B., Erfle V., Pavlakis G.N., Brack-Werner R. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J. Virol. 69:1995;2159-2167.
24. Neumann M., Afonina E., Ceccherini-Silberstein F., Schlicht S., Erfle V., Pavlakis G.N., Brack-Werner R. Nucleocytoplasmic transport in human astrocytes decreased nuclear uptake of the HIV Rev shuttle protein . J. Cell Sci. 114:2001;1717-1729.
25. Neville M., Stutz F., Lee L., Davis L.I., Rosbash M. The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr. Biol. 7:1997;767-775.
26. Henderson B.R., Percipalle P. Interactions between HIV Rev and nuclear import and export factors the Rev nuclear localisation signal mediates specific binding to human importin-beta . J. Mol. Biol. 274:1997;693-707.
27. Askjaer P., Jensen T.H., Nilsson J., Englmeier L., Kjems J. The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP. J. Biol. Chem. 273:1998;33414-33422.
28. Bogerd H.P., Echarri A., Ross T.M., Cullen B.R. Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1. J. Virol. 72:1998;8627-8635.
29. Truant R., Cullen B.R. The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol. Cell. Biol. 19:1999;1210-1217.
30. Malim M.H., Bohnlein S., Hauber J., Cullen B.R. Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell. 58:1989;205-214.
31. Berger J., Aepinus C., Dobrovnik M., Fleckenstein B., Hauber J., Bohnlein E. Mutational analysis of functional domains in the HIV-1 Rev trans-regulatory protein. Virology. 183:1991;630-635.
32. Hammerschmid M., Palmeri D., Ruhl M., Jaksche H., Weichselbraun I., Bohnlein E., Malim M.H., Hauber J. Scanning mutagenesis of the arginine-rich region of the human immunodeficiency virus type 1 Rev trans activator. J. Virol. 68:1994;7329-7335.
33. Venkatesh L.K., Mohammed S., Chinnadurai G. Functional domains of the HIV-1 rev gene required for trans-regulation and subcellular localization. Virology. 176:1990;39-47.
34. Perkins A., Cochrane A.W., Ruben S.M., Rosen C.A. Structural and functional characterization of the human immunodeficiency virus rev protein. J. Acquir. Immune. Defic. Syndr. 2:1989;256-263.
35. Furuta R.A., Kubota S., Maki M., Miyazaki Y., Hattori T., Hatanaka M. Use of a human immunodeficiency virus type 1 Rev mutant without nucleolar dysfunction as a candidate for potential AIDS therapy. J. Virol. 69:1995;1591-1599.
36. Stauber R.H., Afonina E., Gulnik S., Erickson J., Pavlakis G.N. Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells. Virology. 251:1998;38-48.
37. Szilvay A.M., Brokstad K.A., Boe S.O., Haukenes G., Kalland K.H. Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import. Virology. 235:1997;73-81.
38. Nam Y.S., Petrovic A., Jeong K.S., Venkatesan S. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation. J. Virol. 75:2001;2957-2971.
39. Hope T.J., McDonald D., Huang X.J., Low J., Parslow T.G. Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator essential residues near the amino terminus . J. Virol. 64:1990;5360-5366.
40. Ludwig E., Silberstein F.C., van Empel J., Erfle V., Neumann M., Brack-Werner R. Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes. J. Virol. 73:1999;8279-8289.
41. Stauber R.H., Horie K., Carney P., Hudson E.A., Tarasova N.I., Gaitanaris G.A., Pavlakis G.N. Development and applications of enhanced green fluorescent protein mutants. Biotechniques. 24:1998;462-466. 468-471.
42. Anderson D.H. Compartmental Modeling and Tracer Kinetics. 1983;Springer, New York.
43. Fischer U., Huber J., Boelens W.C., Mattaj I.W., Luhrmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 82:1995;475-483.
44. Kudo N., Wolff B., Sekimoto T., Schreiner E.P., Yoneda Y., Yanagida M., Horinouchi S., Yoshida M. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:1998;540-547.
45. Wolff B., Sanglier J.J., Wang Y. Leptomycin B is an inhibitor of nuclear export inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA . Chem. Biol. 4:1997;139-147.
46. Stauber R., Gaitanaris G.A., Pavlakis G.N. Analysis of trafficking of Rev and transdominant Rev proteins in living cells using green fluorescent protein fusions transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm . Virology. 213:1995;439-449.
47. Ribbeck K., Gorlich D. Kinetic analysis of translocation through nuclear pore complexes. EMBO J. 20:2001;1320-1330.
48. Chatterjee S., Stochaj U. Diffusion of proteins across the nuclear envelope of HeLa cells. Biotechniques. 24:1998;668-674.
49. Ishidate T., Yoshihara S., Kawasaki Y., Roy B.C., Toyoshima K., Akiyama T. Identification of a novel nuclear localization signal in Sam68. FEBS Lett. 409:1997;237-241.
50. Szilvay A.M., Brokstad K.A., Kopperud R., Haukenes G., Kalland K.H. Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. J. Virol. 69:1995;3315-3323.
51. Wolff, H., Brack-Werner, R., Neumann, M., Werner, T., Schneider, R., Integrated functional and bioinformatics approach for the identification and experimental verification of RNA signals: application to HIV-1 INS, Nucleic Acids Res. 31 (2003) 2839-2851.
52. Kudo N., Matsumori N., Taoka H., Fujiwara D., Schreiner E.P., Wolff B., Yoshida M., Horinouchi S. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci.USA. 96:1999;9112-9117.
53. D'Agostino D.M., Ciminale V., Pavlakis G.N., Chieco-Bianchi L. Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein involvement of continued rRNA synthesis in nuclear retention . AIDS Res. Hum. Retroviruses. 11:1995;1063-1071.
54. Dundr M., Leno G.H., Hammarskjöld M.-L., Rekosh D., Helga-Maria C., Olson M.O.J. The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein. J. Cell. Sci. 108:1995;2811-2823.
55. Thomas S.L., Oft M., Jaksche H., Casari G., Heger P., Dobrovnik M., Bevec D., Hauber J. Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface. J. Virol. 72:1998;2935-2944.
56. Mosammaparast N., Jackson K.R., Guo Y., Brame C.J., Shabanowitz J., Hunt D.F., Pemberton L.F. Nuclear import of histone H2A and H2B is mediated by a network of karyopherins. J. Cell Biol. 153:2001;251-262.
57. Pemberton L.F., Rosenblum J.S., Blobel G. Nuclear import of the TATA-binding protein mediation by the karyopherin Kap114p and a possible mechanism for intranuclear targeting . J. Cell Biol. 145:1999;1407-1417.
58. Rout M.P., Blobel G., Aitchison J.D. A distinct nuclear import pathway used by ribosomal proteins. Cell. 89:1997;715-725.
59. Reddy T.R., Tang H., Xu W., Wong-Staal F. Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA. Oncogene. 19:2000;3570-3575.
60. Reddy T.R., Xu W.D., Wong-Staal F. General effect of Sam68 on Rev/Rex regulated expression of complex retroviruses. Oncogene. 19:2000;4071-4074.
61. Reddy T.R., Suhasini M., Xu W., Yeh L.Y., Yang J.P., Wu J., Artzt K., Wong-Staal F. A role for KH domain proteins (Sam68-like mammalian proteins and quaking proteins) in the post-transcriptional regulation of HIV replication. J. Biol. Chem. 277:2002;5778-5784.
62. Li J., Liu Y., Park I.W., He J.J. Expression of exogenous Sam68, the 68-kilodalton SRC-associated protein in mitosis, is able to alleviate impaired Rev function in astrocytes. J. Virol. 76:2002;4526-4535.
63. Soros V.B., Carvajal H.V., Richard S., Cochrane A.W. Inhibition of human immunodeficiency virus type 1 Rev function by a dominant-negative mutant of Sam68 through sequestration of unspliced RNA at perinuclear bundles. J. Virol. 75:2001;8203-8215.
64. Efthymiadis A., Dottorini T., Jans D.A. A novel system to quantitate nuclear-cytoplasmic flux in vivo kinetics of signal-dependent nuclear protein export . Arch. Biochem. Biophys. 355:1998;254-261.
65. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90:1997;1051-1060.
66. Kehlenbach R.H., Dickmanns A., Gerace L. Nucleocytoplasmic shuttling factors including Ran and CRM1 mediate nuclear export of NFAT in vitro. J. Cell Biol. 141:1998;863-874.
67. Izaurralde E., Kutay U., von Kobbe C., Mattaj I.W., Gorlich D. The asymmetric distribution of the constituents of the Ran system is essential for transport into and out of the nucleus. EMBO J. 16:1997;6535-6547.
68. Hakata Y., Yamada M., Mabuchi N., Shida H. The carboxy-terminal region of the human immunodeficiency virus type 1 protein Rev has multiple roles in mediating CRM1-related Rev functions. J. Virol. 76:2002;8079-8089.
69. Koffa M.D., Clements J.B., Izaurralde E., Wadd S., Wilson S.A., Mattaj I.W., Kuersten S. Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway. EMBO J. 20:2001;5769-5778.
70. Rudt F., Pieler T. Cytosolic import factor- and Ran-independent nuclear transport of ribosomal protein L5. Eur. J. Cell Biol. 80:2001;661-668.
71. Bui M., Myers J.E., Whittaker G.R. Nucleo-cytoplasmic localization of influenza virus nucleoprotein depends on cell density and phosphorylation. Virus Res. 84:2002;37-44.
72. 134.5 protein of herpes simplex virus type 1. J. Virol. 76:2002;9434-9445.
73. Sherman M.P., de Noronha C.M., Heusch M.I., Greene S., Greene W.C. Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr. J. Virol. 75:2001;1522-1532.
74. Mermer B., Felber B.K., Campbell M., Pavlakis G.N. Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Res. 18:1990;2037-2044.